Evox Therapeutics
高管
查看带有其 12 名主要高管的组织结构图
Evox Therapeutics 搜索最多的简介
- Per Lundin, Chief Executive Officer and Director
- Amrit Nagpal, Non-Executive Director
- Evan Caplan, Director
高管在Evox Therapeutics变化
- Per Lundin 曾任 Chief Business Officer, 现升职为 Chief Executive Officer and Director (新闻发布的2024四月29号).
- Antonin de Fougerolles, Chief Executive Officer and Director, 已经离开公司 (新闻发布的2024四月29号).
创建提醒
跟踪 Evox Therapeutics 的高管变动
生物技术
Evox Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Evox Therapeutics 的最新新闻稿
- Events - Evox Therapeutics
- Events - Evox Therapeutics
- Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio - Evox Therapeutics
- Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform with Nine Pr - Evox Therapeutics
- Evox Therapeutics to Present at the 2022 Jefferies Healthcare Conference - Evox Therapeutics
- Evox Therapeutics Announces Data Presentations at the International Society for Extracellular Vesicl - Evox Therapeutics
- Evox Therapeutics Appoints Peter Jones as Vice President of CMC - Evox Therapeutics
- International Society for Cell & Gene Therapy Presentations Illustrate Evox Therapeutics’ Proprietar - Evox Therapeutics
- View more press releases Close
通过电子邮件
